Ignite Creation Date:
2025-12-24 @ 3:54 PM
Ignite Modification Date:
2026-02-25 @ 9:45 PM
Study NCT ID:
NCT03828292
Status:
COMPLETED
Last Update Posted:
2025-08-19
First Post:
2019-01-31
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Open-label, Dose Escalation Study in Japanese Participants With Relapsed/Refractory Multiple Myeloma Who Have Failed Prior Anti Myeloma Treatments
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-14
Start Date Type:
ACTUAL
Primary Completion Date:
2023-04-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-09-05
Completion Date Type:
ACTUAL
First Submit Date:
2019-01-31
First Submit QC Date:
None
Study First Post Date:
2019-02-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-04-05
Results First Submit QC Date:
None
Results First Post Date:
2025-04-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-01
Last Update Post Date:
2025-08-19
Last Update Post Date Type:
ACTUAL